Related Experiment Video
Updated: Jul 31, 2025

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Dissecting the effects of GTPase and kinase domain mutations on LRRK2 endosomal localization and activity
Capria Rinaldi1, Christopher S Waters1, Zizheng Li1
1Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Abstract:
Parkinson's disease-causing leucine-rich repeat kinase 2 (LRRK2) mutations lead to varying degrees of Rab GTPase hyperphosphorylation. Puzzlingly, LRRK2 GTPase-inactivating mutations-which do not affect intrinsic kinase activity-lead to higher levels of cellular Rab phosphorylation than kinase-activating mutations. Here, we investigate whether mutation-dependent differences in LRRK2 cellular localization could explain this discrepancy. We discover that blocking endosomal maturation leads to the rapid formation of mutant LRRK2+ endosomes on which LRRK2 phosphorylates substrate Rabs. LRRK2+ endosomes are maintained through positive feedback, which mutually reinforces membrane localization of LRRK2 and phosphorylated Rab substrates. Furthermore, across a panel of mutants, cells expressing GTPase-inactivating mutants form strikingly more LRRK2+ endosomes than cells expressing kinase-activating mutants, resulting in higher total cellular levels of phosphorylated Rabs. Our study suggests that the increased probability that LRRK2 GTPase-inactivating mutants are retained on intracellular membranes compared to kinase-activating mutants leads to higher substrate phosphorylation.
Insights
Mutant leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease localizes differently, with GTPase-inactivating mutations forming more endosomes and increasing Rab phosphorylation compared to kinase-activating mutations.
Area of Science:
- Cell Biology
- Neuroscience
- Biochemistry
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are a major genetic cause of Parkinson's disease.
- LRRK2 mutations are associated with altered Rab GTPase phosphorylation, but the mechanism is unclear.
- GTPase-inactivating LRRK2 mutations paradoxically increase Rab phosphorylation more than kinase-activating mutations.
Purpose of the Study:
- To investigate if differential cellular localization of mutant LRRK2 explains varying Rab phosphorylation levels.
- To explore the role of endosomal maturation and positive feedback in LRRK2 localization and activity.
Main Methods:
- Utilized cell-based assays to observe LRRK2 localization and Rab phosphorylation.
- Manipulated endosomal maturation to induce LRRK2+ endosome formation.
- Analyzed localization patterns of various LRRK2 mutants.
Main Results:
- Blocking endosomal maturation rapidly formed mutant LRRK2+ endosomes, sites of Rab phosphorylation.
- LRRK2+ endosomes exhibited positive feedback, reinforcing LRRK2 and pRab localization.
- GTPase-inactivating LRRK2 mutants formed significantly more LRRK2+ endosomes than kinase-activating mutants.
- This resulted in higher overall cellular levels of phosphorylated Rab GTPases.
Conclusions:
- Altered cellular localization, specifically increased retention on intracellular membranes, underlies the higher Rab phosphorylation observed with GTPase-inactivating LRRK2 mutants.
- This finding provides a novel mechanistic link between LRRK2 mutation type, subcellular localization, and Parkinson's disease pathogenesis.
Related Concept Videos
Lysosomal Hydrolases
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins,...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade

